Its good to watch for any bad reactions and teach patients how to handle them
Potential limitations include: Limited long-term human data Variable patient response Cost considerations Need for ongoing monitoring Off-label prescribing considerations These therapies are generally avoided in patients with: Active malignancy Pregnancy or breastfeeding Significant uncontrolled endocrine disease Certain metabolic conditions Monitoring and Safety Where prescribed, monitoring may include: IGF-1 levels Functional recovery Sleep quality Rehabilitation tolerance Adverse effects Overall clinical progress Treatment should always be part of a broader recovery plan rather than a standalone intervention
If using a fire, hurricane, or flood damage restoration company, make sure to ask what type of products they use
Oncotarget 8:102653102673 Ichihara M, Sobue S, Ito M, Ito M, Hirayama M, Ohno K (2015) Beneficial biological effects and the underlying mechanisms of molecular hydrogen-comprehensive review of 321 original articles
Despite the claims on their website, there is no verifiable proof that HHVB GLP-1 drops are approved by the Therapeutic Goods Administration (TGA) or the U.S